Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | ALB | P02768 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12587111 | 0.84 | TTR (0.36) | TTRALBMEN1KMT2A | |
| SCHEMBL504640 | 0.77 | TTR (0.52) | TTRALBMEN1KMT2APGR | |
| SCHEMBL200313 | 0.77 | TTR (0.52) | TTRALBMEN1KMT2APGR | |
| SCHEMBL12798241 | 0.75 | GRM5 (0.35) | PGR | |
| SCHEMBL10251503 | 0.75 | TTR (0.39) | TTRALBMEN1KMT2A | |
| SCHEMBL12399933 | 0.75 | ALDH1A1 (0.38) | TTRALBMEN1KMT2APGR | |
| SCHEMBL12399938 | 0.75 | MEN1 (0.31) | TTRALBMEN1KMT2A | |
| SCHEMBL12551765 | 0.72 | LOXL2 (0.31) | — | |
| SCHEMBL12399930 | 0.71 | GRM5 (0.35) | TTRALBMEN1KMT2A | |
| SCHEMBL12399929 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301181-A1 | TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
| US-9045510-B2 | Iridium complex, organic light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-06-02 | — | — | US | disclosed |
| US-8921359-B2 | Inhibitors of beta-secretase | VITAE PHARMACEUTICALS, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-8450308-B2 | Inhibitors of beta-secretase | VITAE PHARMACEUTICALS, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-20120273769-A1 | NOVEL IRIDIUM COMPLEX, ORGANIC LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-11-01 | — | — | US | disclosed |
| US-20110218192-A1 | Inhibitors Of Beta-Secretase | VITAE PHARMACEUTICALS, INC. (US) | 2011-09-08 | — | — | US | disclosed |
| US-20070111024-A1 | Metal complex compound and organic electroluminescence device containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149414-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | TTR 3059/4885ALB 4644/4885MEN1 1366/4885 |
| US-20110218192-A1 | Inhibitors Of Beta-Secretase | BACE1, BACE2, APP | TTR 1344/4885ALB 4757/4885MEN1 813/4885 |
| US-20230301181-A1 | TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SAT1, FTO, SETDB1 | TTR 3424/4885ALB 1381/4885MEN1 2032/4885 |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | OR10J3, RPS10, OR51E2 | TTR 2471/4885ALB 907/4885MEN1 833/4885 |
| US-20120273769-A1 | NOVEL IRIDIUM COMPLEX, ORGANIC LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ZKSCAN2, OCIAD1, OCIAD2 | TTR 4477/4885ALB 3165/4885MEN1 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.